TOPOTECAN

TOPOTECAN was reported 6124 times

TOPOTECAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MICROCYSTIC MACULAR OEDEMA 4 0.5714
1 DESMOPLASTIC SMALL ROUND CELL TUMOUR 40 0.4598
2 GENOTOXICITY 13 0.3421
3 NEUROENDOCRINE CARCINOMA OF THE CERVIX 5 0.3333
4 RHABDOMYOSARCOMA RECURRENT 11 0.2558
5 HETEROCHROMIA IRIDIS 7 0.2500
6 PRIMITIVE NEUROECTODERMAL TUMOUR 13 0.2407
7 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 15 0.2273
8 ADENOSQUAMOUS CELL CARCINOMA 3 0.1667
9 ALVEOLAR SOFT PART SARCOMA 6 0.1622
10 VULVAL CANCER METASTATIC 4 0.1600
11 ALVEOLAR RHABDOMYOSARCOMA 7 0.1591
12 DIFFUSION-WEIGHTED BRAIN MRI ABNORMAL 4 0.1481
13 CHOROIDAL DYSTROPHY 7 0.1458
14 CHOROIDAL INFARCTION 17 0.1417
15 NEUROBLASTOMA RECURRENT 27 0.1330
16 STAPHYLOMA 4 0.1290
17 CHORIORETINAL ATROPHY 23 0.1111
18 NEUROBLASTOMA 40 0.1044
19 OPHTHALMIC ARTERY OCCLUSION 6 0.1034
20 ORBITAL HAEMORRHAGE 3 0.0968
21 NEPHROBLASTOMA 12 0.0945
22 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 11 0.0902
23 RETINOBLASTOMA 9 0.0826
24 UNDIFFERENTIATED SARCOMA 4 0.0784
25 OVARIAN CLEAR CELL CARCINOMA 3 0.0769
26 GRANULICATELLA INFECTION 3 0.0714
27 ENOPHTHALMOS 7 0.0693
28 NEURODEVELOPMENTAL DELAY 3 0.0652
29 IRIS ATROPHY 12 0.0580
30 SMALL CELL LUNG CANCER STAGE UNSPECIFIED 21 0.0574
31 CHROMOSOMAL DELETION 9 0.0566
32 MEDULLOBLASTOMA 8 0.0537
33 ATROPHY OF GLOBE 6 0.0469
34 CORYNEBACTERIUM SEPSIS 3 0.0455
35 RETINAL DEPIGMENTATION 13 0.0425
36 RETINOPATHY PROLIFERATIVE 8 0.0410
37 RHEGMATOGENOUS RETINAL DETACHMENT 8 0.0383
38 CHORIORETINAL SCAR 3 0.0361
39 MEDULLOBLASTOMA RECURRENT 4 0.0354
40 CERVIX CARCINOMA RECURRENT 6 0.0337
41 ACHROMOBACTER INFECTION 4 0.0333
42 BRAIN STEM GLIOMA 5 0.0329
43 METASTASES TO THYROID 3 0.0326
44 PINEALOBLASTOMA 3 0.0323
45 ADMINISTRATION RELATED REACTION 6 0.0308
46 CERVIX CANCER METASTATIC 5 0.0303
47 LENTICULAR OPACITIES 13 0.0297
48 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 5 0.0287
49 CHROMOSOME ANALYSIS ABNORMAL 7 0.0276
50 METASTATIC BRONCHIAL CARCINOMA 5 0.0260
51 METASTASES TO BONE MARROW 13 0.0260
52 HUMAN METAPNEUMOVIRUS TEST POSITIVE 3 0.0254
53 VISUAL PATHWAY DISORDER 4 0.0248
54 METASTASES TO HEART 7 0.0232
55 SQUAMOUS CELL CARCINOMA OF THE CERVIX 5 0.0225
56 PROTEUS TEST POSITIVE 5 0.0223
57 CRANIAL NERVE PALSIES MULTIPLE 3 0.0214
58 RHABDOMYOSARCOMA 4 0.0213
59 CAECITIS 9 0.0200
60 SYMBLEPHARON 5 0.0192
61 SHORT STATURE 5 0.0191
62 NEUTROPHIL COUNT 4 0.0190
63 REFRACTORY CANCER 4 0.0187
64 METASTASES TO PANCREAS 8 0.0181
65 ORBITAL OEDEMA 9 0.0178
66 ACUTE MYELOID LEUKAEMIA REFRACTORY 3 0.0174
67 UREAPLASMA INFECTION 7 0.0172
68 INTESTINAL METASTASIS 6 0.0165
69 VITREOUS HAEMORRHAGE 45 0.0163
70 PULMONARY HILUM MASS 3 0.0160
71 CHORIORETINAL DISORDER 3 0.0152
72 BASOPHIL COUNT DECREASED 4 0.0152
73 OVARIAN CANCER RECURRENT 24 0.0149
74 CRANIAL NERVE PARALYSIS 7 0.0148
75 CATARACT SUBCAPSULAR 9 0.0148
76 EYE EXCISION 3 0.0146
77 ADENOCARCINOMA METASTATIC 3 0.0146
78 EYELID RASH 14 0.0143
79 CHLOROMA 6 0.0142
80 ANAL INFLAMMATION 9 0.0141
81 METAPNEUMOVIRUS INFECTION 11 0.0140
82 RETINAL PIGMENT EPITHELIOPATHY 6 0.0139
83 IRIS ADHESIONS 7 0.0136
84 EPIPHYSES PREMATURE FUSION 4 0.0132
85 CEREBRAL CYST 9 0.0131
86 OSTEOSARCOMA 5 0.0130
87 METASTASES TO STOMACH 5 0.0128
88 METASTASES TO PERITONEUM 31 0.0123
89 METASTASES TO ABDOMINAL CAVITY 6 0.0122
90 ACUTE MYELOMONOCYTIC LEUKAEMIA 3 0.0119
91 FEBRILE BONE MARROW APLASIA 50 0.0118
92 ANAL INFECTION 3 0.0117
93 SMALL CELL CARCINOMA 4 0.0116
94 COLONIC OBSTRUCTION 3 0.0115
95 RETINAL ISCHAEMIA 7 0.0115
96 BONE MARROW DEPRESSION 11 0.0113
97 RECTAL PERFORATION 6 0.0111
98 IIIRD NERVE PARALYSIS 9 0.0111
99 PANCREATIC DUCT DILATATION 3 0.0109
100 RETINAL VASCULAR OCCLUSION 8 0.0108
101 VITH NERVE PARALYSIS 12 0.0105
102 SARS-COV-2 TEST NEGATIVE 7 0.0104
103 MACULAR FIBROSIS 7 0.0103
104 THERAPY RESPONDER 5 0.0102
105 HYPERLEUKOCYTOSIS 9 0.0102
106 NEOPLASM RECURRENCE 34 0.0100
107 RETINAL DEGENERATION 13 0.0100
108 BRAIN COMPRESSION 4 0.0100
109 DYSPNOEA EXACERBATED 5 0.0097
110 OVARIAN CANCER STAGE IV 4 0.0096
111 OVARIAN CANCER METASTATIC 8 0.0094
112 SMALL CELL LUNG CANCER 14 0.0093
113 HAEMATOTOXICITY 88 0.0093
114 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 6 0.0092
115 BRONCHOSTENOSIS 5 0.0091
116 MALIGNANT ASCITES 7 0.0091
117 CENTRAL HYPOTHYROIDISM 3 0.0091
118 BLOOD LACTATE DEHYDROGENASE DECREASED 3 0.0090
119 BILIARY SEPSIS 4 0.0086
120 RESPIRATORY TRACT INFLAMMATION 4 0.0086
121 RETINAL VASCULAR DISORDER 5 0.0085
122 PLATELET TRANSFUSION 11 0.0085
123 MYELITIS TRANSVERSE 12 0.0085
124 CHRONIC RESPIRATORY DISEASE 3 0.0085
125 AIR EMBOLISM 4 0.0085
126 CYSTITIS ESCHERICHIA 3 0.0084
127 VITREOUS DISORDER 4 0.0083
128 SUPERIOR VENA CAVA SYNDROME 5 0.0083
129 MONOCYTE COUNT DECREASED 10 0.0082
130 HYDROURETER 3 0.0079
131 CANDIDA SEPSIS 7 0.0078
132 INTRACRANIAL TUMOUR HAEMORRHAGE 3 0.0078
133 BLADDER PERFORATION 3 0.0078
134 PERITONEAL DISORDER 5 0.0077
135 METASTASES TO LYMPH NODES 52 0.0077
136 SUBILEUS 16 0.0077
137 METASTASES TO KIDNEY 4 0.0073
138 THROMBOCYTHAEMIA 4 0.0072
139 CANDIDA TEST POSITIVE 3 0.0072
140 MENINGITIS BACTERIAL 10 0.0070
141 ENTEROVIRUS INFECTION 6 0.0069
142 HYPOPITUITARISM 12 0.0069
143 RETINAL TOXICITY 7 0.0068
144 ENGRAFTMENT SYNDROME 4 0.0068
145 CARBOHYDRATE ANTIGEN 125 INCREASED 23 0.0067
146 DEAFNESS NEUROSENSORY 22 0.0067
147 BLOOD CULTURE POSITIVE 20 0.0067
148 FEEDING INTOLERANCE 3 0.0067
149 ENTEROVESICAL FISTULA 5 0.0066
150 FEBRILE NEUTROPENIA 427 0.0064
151 OVARIAN CANCER 58 0.0063
152 ABDOMINAL COMPARTMENT SYNDROME 4 0.0063
153 PSEUDOMONAL SEPSIS 11 0.0063
154 NEUTROPENIC INFECTION 6 0.0063
155 NECROTISING RETINITIS 4 0.0063
156 HAEMOPERITONEUM 5 0.0062
157 ENTEROCOCCUS TEST POSITIVE 4 0.0062
158 OPTIC ATROPHY 10 0.0061
159 PROTEIN TOTAL DECREASED 23 0.0061
160 MESENTERIC VEIN THROMBOSIS 6 0.0060
161 SEROUS RETINAL DETACHMENT 5 0.0060
162 OTOTOXICITY 11 0.0059
163 PARAINFLUENZAE VIRUS INFECTION 9 0.0059
164 BLOOD CHLORIDE DECREASED 15 0.0058
165 NEUROENDOCRINE CARCINOMA 4 0.0058
166 ARACHNOIDITIS 4 0.0058
167 ACUTE MYELOID LEUKAEMIA 90 0.0058
168 MYELODYSPLASTIC SYNDROME TRANSFORMATION 3 0.0058
169 PLASMAPHERESIS 3 0.0057
170 MENINGITIS CRYPTOCOCCAL 10 0.0057
171 CYTOMEGALOVIRUS CHORIORETINITIS 11 0.0056
172 HYDRONEPHROSIS 42 0.0056
173 IRIS DISORDER 3 0.0056
174 BLOOD GASES ABNORMAL 3 0.0056
175 CHYLOTHORAX 4 0.0055
176 OSTEOMYELITIS ACUTE 3 0.0055
177 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
178 HYPOPROTEINAEMIA 10 0.0053
179 VENOOCCLUSIVE LIVER DISEASE 26 0.0053
180 THERAPY PARTIAL RESPONDER 81 0.0052
181 PLATELET COUNT 3 0.0052
182 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 12 0.0052
183 ASEPTIC NECROSIS BONE 4 0.0051
184 LYMPHOPENIA 72 0.0051
185 GASTROINTESTINAL PERFORATION 21 0.0050
186 PERIPHERAL ARTERY THROMBOSIS 7 0.0050
187 CULTURE URINE POSITIVE 7 0.0050
188 AUTONOMIC NEUROPATHY 5 0.0049
189 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
190 TUMOUR HAEMORRHAGE 14 0.0049
191 MUCOSAL INFLAMMATION 128 0.0049
192 RECALL PHENOMENON 4 0.0048
193 METASTASES TO PLEURA 5 0.0048
194 METASTASES TO PELVIS 3 0.0047
195 NEUTROPHIL COUNT DECREASED 192 0.0047
196 FEMALE GENITAL TRACT FISTULA 8 0.0047
197 BRONCHOSPASM 66 0.0046
198 APLASIA 9 0.0046
199 TRANSFUSION REACTION 4 0.0046
200 ILEAL PERFORATION 3 0.0045
201 BONE MARROW FAILURE 90 0.0044
202 VENOOCCLUSIVE DISEASE 11 0.0044
203 AORTITIS 3 0.0044
204 PANCYTOPENIA 241 0.0043
205 HEPATOSPLENOMEGALY 11 0.0043
206 CHORIORETINOPATHY 6 0.0042
207 RADIATION PNEUMONITIS 9 0.0042
208 EXOPHTHALMOS 9 0.0042
209 MYELODYSPLASTIC SYNDROME 60 0.0041
210 CLOSTRIDIUM COLITIS 5 0.0041
211 BLOOD ELECTROLYTES ABNORMAL 5 0.0040
212 ARTERIAL INJURY 3 0.0040
213 METASTASES TO LIVER 70 0.0040
214 MUCOSAL ULCERATION 4 0.0040
215 METASTASES TO MENINGES 9 0.0040
216 ILEUS 49 0.0039
217 GLUCOSE URINE PRESENT 5 0.0039
218 PLEURAL FIBROSIS 4 0.0039
219 CONJUNCTIVAL OEDEMA 4 0.0039
220 NEUTROPHIL COUNT ABNORMAL 11 0.0039
221 ASPERGILLOSIS 5 0.0038
222 ACQUIRED GENE MUTATION 5 0.0038
223 ENDOCARDITIS BACTERIAL 3 0.0038
224 CARDIOTOXICITY 34 0.0038
225 PNEUMONIA FUNGAL 15 0.0038
226 HAEMOTHORAX 11 0.0038
227 VASCULAR OCCLUSION 8 0.0038
228 TUMOUR NECROSIS 4 0.0038
229 ENTEROCOCCAL BACTERAEMIA 4 0.0038
230 POLYOMAVIRUS VIRAEMIA 4 0.0038
231 SCLERITIS 6 0.0037
232 MACULAR HOLE 5 0.0037
233 CYSTOID MACULAR OEDEMA 7 0.0037
234 DISEASE PROGRESSION 439 0.0037
235 RESPIRATORY ALKALOSIS 6 0.0037
236 MYELOPATHY 7 0.0037
237 PSEUDOMONAS TEST POSITIVE 3 0.0037
238 POLYCYTHAEMIA VERA 3 0.0037
239 OCULAR VASCULAR DISORDER 3 0.0036
240 ASCITES 107 0.0036
241 THROMBOCYTOPENIA 407 0.0036
242 OCULAR TOXICITY 4 0.0036
243 PERITONEAL HAEMORRHAGE 5 0.0036
244 HYPERAMMONAEMIA 18 0.0036
245 CULTURE POSITIVE 3 0.0036
246 NEUTROPENIA 486 0.0036
247 MALIGNANT PLEURAL EFFUSION 6 0.0036
248 BLOOD AMYLASE INCREASED 6 0.0035
249 RED BLOOD CELL COUNT DECREASED 100 0.0035
250 PELVIC ABSCESS 4 0.0035
251 NEOPLASM PROGRESSION 121 0.0035
252 NOROVIRUS INFECTION 5 0.0035
253 BONE MARROW TOXICITY 4 0.0034
254 NEUTROPENIC SEPSIS 24 0.0034
255 MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0033
256 RHINOVIRUS INFECTION 13 0.0033
257 ISCHAEMIA 15 0.0033
258 CYSTITIS HAEMORRHAGIC 13 0.0032
259 BLOOD UREA DECREASED 4 0.0032
260 RETINOPATHY 12 0.0032
261 HYPOALBUMINAEMIA 25 0.0032
262 METASTASES TO CENTRAL NERVOUS SYSTEM 41 0.0032
263 BONE MARROW TRANSPLANT 6 0.0032
264 BACTERIAL TEST POSITIVE 7 0.0031
265 CANCER PAIN 8 0.0031
266 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
267 BICYTOPENIA 6 0.0031
268 OXYGEN THERAPY 5 0.0030
269 PACKED RED BLOOD CELL TRANSFUSION 4 0.0030
270 CATHETER RELATED INFECTION 3 0.0030
271 CLOSTRIDIAL INFECTION 10 0.0030
272 URINARY TRACT OBSTRUCTION 7 0.0029
273 EOSINOPHIL COUNT DECREASED 7 0.0029
274 URETERIC OBSTRUCTION 4 0.0029
275 MALIGNANT NEOPLASM PROGRESSION 300 0.0029
276 METASTASES TO BONE 48 0.0029
277 ENTEROCOCCAL INFECTION 14 0.0029
278 SECOND PRIMARY MALIGNANCY 24 0.0029
279 RENAL TUBULAR DISORDER 8 0.0028
280 LEUKOPENIA 141 0.0028
281 INTENSIVE CARE 4 0.0028
282 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
283 PNEUMONIA KLEBSIELLA 5 0.0027
284 GASTROINTESTINAL TOXICITY 13 0.0027
285 ANAEMIA 513 0.0027
286 LEUKOENCEPHALOPATHY 10 0.0027
287 WHITE BLOOD CELLS URINE POSITIVE 5 0.0027
288 WHITE BLOOD CELL COUNT DECREASED 282 0.0026
289 ARTERIAL THROMBOSIS 5 0.0026
290 EYELID OEDEMA 30 0.0026
291 CUTANEOUS LUPUS ERYTHEMATOSUS 5 0.0026
292 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
293 HYPOCHLORAEMIA 3 0.0026
294 HYPOMAGNESAEMIA 35 0.0025
295 DRUG TOXICITY 34 0.0025
296 SKIN TOXICITY 14 0.0025
297 OESOPHAGEAL STENOSIS 7 0.0025
298 THROMBOCYTOSIS 9 0.0025
299 CAPILLARY LEAK SYNDROME 5 0.0024
300 DRUG RESISTANCE 62 0.0024
301 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
302 RETINAL DETACHMENT 22 0.0024
303 SYSTEMIC CANDIDA 6 0.0024
304 HYDROCEPHALUS 13 0.0024
305 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 4 0.0024
306 PLATELET COUNT DECREASED 250 0.0023
307 ANOREXIA 30 0.0023
308 BILIARY OBSTRUCTION 3 0.0023
309 FAILURE TO THRIVE 12 0.0023
310 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
311 EYELID PTOSIS 23 0.0023
312 CONJUNCTIVAL HYPERAEMIA 8 0.0022
313 RENAL FAILURE CHRONIC 17 0.0022
314 HYPOTONIA 22 0.0022
315 BLOOD PHOSPHORUS INCREASED 6 0.0022
316 PULMONARY HAEMORRHAGE 17 0.0022
317 NEUROLOGICAL DECOMPENSATION 5 0.0022
318 BACTERIAL SEPSIS 7 0.0021
319 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
320 BLOOD ALBUMIN DECREASED 17 0.0021
321 BRONCHIAL OBSTRUCTION 3 0.0021
322 CYTOPENIA 26 0.0021
323 PULMONARY TOXICITY 15 0.0021
324 PERIORBITAL OEDEMA 11 0.0021
325 RADIOTHERAPY 4 0.0021
326 METASTATIC NEOPLASM 9 0.0021
327 LUNG CANCER METASTATIC 6 0.0021
328 ENTEROCOLITIS 12 0.0021
329 METASTASES TO LUNG 24 0.0021
330 OPTIC ISCHAEMIC NEUROPATHY 8 0.0021
331 BILIARY DILATATION 3 0.0020
332 SMALL INTESTINAL OBSTRUCTION 25 0.0020
333 HOSPICE CARE 20 0.0020
334 PROTEIN URINE PRESENT 10 0.0020
335 STEM CELL TRANSPLANT 5 0.0020
336 FOAMING AT MOUTH 4 0.0020
337 RECURRENT CANCER 8 0.0020
338 INTESTINAL PERFORATION 22 0.0020
339 NEUTROPENIC COLITIS 4 0.0019
340 ONYCHOLYSIS 3 0.0019
341 FUNGAEMIA 3 0.0019
342 PNEUMONIA LEGIONELLA 3 0.0019
343 LARGE INTESTINE PERFORATION 13 0.0019
344 ABDOMINAL MASS 5 0.0019
345 PSEUDOMONAS INFECTION 16 0.0019
346 OCULOGYRIC CRISIS 4 0.0019
347 CATHETER SITE INFECTION 7 0.0018
348 THROMBOTIC MICROANGIOPATHY 18 0.0018
349 ORAL FUNGAL INFECTION 5 0.0018
350 CEREBELLAR SYNDROME 4 0.0018
351 PAPILLOEDEMA 8 0.0018
352 OESOPHAGEAL PAIN 7 0.0018
353 DEAFNESS BILATERAL 3 0.0018
354 BLOOD CHLORIDE INCREASED 3 0.0017
355 HYPOKALAEMIA 80 0.0017
356 ESCHERICHIA SEPSIS 5 0.0017
357 MADAROSIS 20 0.0017
358 PROCTALGIA 11 0.0017
359 BLOOD LACTIC ACID INCREASED 9 0.0017
360 METASTASIS 12 0.0017
361 VARICELLA 4 0.0017
362 BLOOD UREA INCREASED 28 0.0017
363 MYOSITIS 15 0.0017
364 DIABETES INSIPIDUS 4 0.0017
365 ORAL INTAKE REDUCED 4 0.0017
366 MONOCYTE COUNT INCREASED 6 0.0017
367 ADRENAL INSUFFICIENCY 20 0.0016
368 OESOPHAGITIS 18 0.0016
369 EYE INJURY 5 0.0016
370 DERMATITIS ACNEIFORM 10 0.0016
371 FAECALOMA 9 0.0016
372 HYPERBILIRUBINAEMIA 17 0.0016
373 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
374 PNEUMOPERITONEUM 3 0.0016
375 PYELONEPHRITIS 14 0.0016
376 MULTIPLE-DRUG RESISTANCE 5 0.0016
377 FLANK PAIN 15 0.0016
378 BLOOD CREATININE DECREASED 5 0.0016
379 SWELLING OF EYELID 10 0.0016
380 KLEBSIELLA INFECTION 8 0.0016
381 BLOOD CREATINE INCREASED 7 0.0016
382 WHITE BLOOD CELL COUNT ABNORMAL 10 0.0016
383 EMBOLISM 13 0.0016
384 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
385 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
386 HEPATITIS TOXIC 4 0.0015
387 APLASTIC ANAEMIA 8 0.0015
388 VENOUS THROMBOSIS 6 0.0015
389 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
390 EXFOLIATIVE RASH 4 0.0015
391 GENE MUTATION 3 0.0015
392 AREFLEXIA 4 0.0015
393 RESPIRATORY DISTRESS 41 0.0015
394 BLOOD BILIRUBIN INCREASED 40 0.0015
395 HAEMATOCRIT DECREASED 29 0.0015
396 ATELECTASIS 14 0.0014
397 LIPASE INCREASED 11 0.0014
398 BLOOD SODIUM DECREASED 27 0.0014
399 NEUROGENIC BLADDER 3 0.0014
400 HYPERVOLAEMIA 7 0.0014
401 LYMPHOCYTE COUNT DECREASED 25 0.0014
402 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
403 CATHETER SITE ERYTHEMA 3 0.0014
404 HAEMOGLOBIN DECREASED 143 0.0014
405 FACIAL PALSY 3 0.0014
406 ELECTROLYTE IMBALANCE 16 0.0014
407 HYPERTRIGLYCERIDAEMIA 8 0.0014
408 STRABISMUS 4 0.0014
409 CLOSTRIDIUM TEST POSITIVE 3 0.0014
410 CEREBRAL ISCHAEMIA 7 0.0014
411 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
412 CEREBRAL DISORDER 10 0.0014
413 TRANSFUSION 14 0.0013
414 MENTAL STATUS CHANGES 37 0.0013
415 TACHYPNOEA 18 0.0013
416 PLATELET COUNT ABNORMAL 8 0.0013
417 HEPATOMEGALY 13 0.0013
418 PRODUCT USE IN UNAPPROVED INDICATION 326 0.0013
419 PROTEINURIA 25 0.0013
420 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
421 UROSEPSIS 12 0.0013
422 PERFORMANCE STATUS DECREASED 6 0.0013
423 INVESTIGATION 4 0.0013
424 MULTI-ORGAN FAILURE 22 0.0013
425 HYPOCALCAEMIA 24 0.0013
426 RETINAL HAEMORRHAGE 9 0.0013
427 LUNG INFILTRATION 11 0.0012
428 ACUTE RESPIRATORY DISTRESS SYNDROME 22 0.0012
429 PAINFUL RESPIRATION 3 0.0012
430 RASH VESICULAR 6 0.0012
431 LYMPHOCYTE COUNT INCREASED 4 0.0012
432 BREATH SOUNDS ABNORMAL 6 0.0012
433 ESCHERICHIA INFECTION 10 0.0012
434 STAPHYLOCOCCAL SEPSIS 6 0.0012
435 PNEUMONIA BACTERIAL 11 0.0012
436 INTERSTITIAL LUNG DISEASE 58 0.0012
437 SEPTIC SHOCK 52 0.0012
438 METASTASES TO SPINE 4 0.0012
439 HAEMODYNAMIC INSTABILITY 9 0.0012
440 BACTERAEMIA 14 0.0012
441 HAEMORRHAGE URINARY TRACT 3 0.0012
442 ABDOMINAL INFECTION 3 0.0012
443 CACHEXIA 6 0.0012
444 MYELOSUPPRESSION 41 0.0011
445 TUMOUR LYSIS SYNDROME 10 0.0011
446 HYPOXIA 40 0.0011
447 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
448 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
449 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
450 BLOOD SODIUM INCREASED 3 0.0011
451 SEPSIS 124 0.0011
452 BONE LESION 4 0.0011
453 SHOCK HAEMORRHAGIC 9 0.0011
454 DEVICE RELATED INFECTION 17 0.0011
455 HAEMOGLOBIN ABNORMAL 7 0.0011
456 PLEURAL EFFUSION 66 0.0011
457 HYPONATRAEMIA 61 0.0011
458 CARDIAC DYSFUNCTION 4 0.0011
459 PLATELET COUNT INCREASED 14 0.0011
460 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
461 PROCTITIS 3 0.0011
462 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
463 NEPHROPATHY TOXIC 12 0.0011
464 BLOOD CALCIUM DECREASED 12 0.0011
465 IMMUNE THROMBOCYTOPENIC PURPURA 3 0.0011
466 PERIORBITAL SWELLING 6 0.0011
467 PETECHIAE 11 0.0011
468 HAEMATOLOGICAL MALIGNANCY 3 0.0011
469 CARDIAC TAMPONADE 5 0.0011
470 DISEASE RECURRENCE 50 0.0011
471 HYPERTHERMIA 8 0.0010
472 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
473 HYPOVOLAEMIC SHOCK 5 0.0010
474 BLOOD MAGNESIUM DECREASED 9 0.0010
475 EPISTAXIS 78 0.0010
476 FAECAL INCONTINENCE 5 0.0010
477 ADENOVIRUS INFECTION 3 0.0010
478 URINE OUTPUT DECREASED 9 0.0010
479 BODY TEMPERATURE INCREASED 21 0.0010
480 CERVIX CARCINOMA 4 0.0010
481 INTRAOCULAR PRESSURE INCREASED 13 0.0010
482 RESPIRATORY FAILURE 74 0.0010
483 ENCEPHALITIS 7 0.0010
484 GENERAL PHYSICAL HEALTH DETERIORATION 117 0.0010
485 BRAIN HERNIATION 3 0.0010
486 OESOPHAGEAL CANDIDIASIS 4 0.0010
487 CANDIDIASIS 4 0.0010
488 BONE MARROW DISORDER 3 0.0010
489 EMBOLISM VENOUS 3 0.0010
490 FISTULA 11 0.0010
491 CHEST X-RAY ABNORMAL 3 0.0010
492 COLITIS 37 0.0010
493 DIARRHOEA HAEMORRHAGIC 9 0.0010
494 C-REACTIVE PROTEIN INCREASED 35 0.0010
495 PYREXIA 332 0.0010
496 ABDOMINAL ADHESIONS 3 0.0009
497 NON-CARDIAC CHEST PAIN 3 0.0009
498 CANDIDA INFECTION 16 0.0009
499 PNEUMOTHORAX 15 0.0009
500 ORTHOPNOEA 3 0.0009
501 LUNG NEOPLASM 4 0.0009
502 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
503 HAEMATURIA 32 0.0009
504 BLOOD TEST ABNORMAL 13 0.0009
505 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
506 ACCIDENT 11 0.0009
507 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
508 NO THERAPEUTIC RESPONSE 11 0.0009
509 EJECTION FRACTION DECREASED 14 0.0009
510 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
511 NECROSIS 5 0.0009
512 ILEUS PARALYTIC 4 0.0009
513 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
514 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
515 TACHYCARDIA 77 0.0009
516 GRAND MAL CONVULSION 8 0.0009
517 BLOOD URIC ACID INCREASED 5 0.0009
518 HYPERTRANSAMINASAEMIA 6 0.0009
519 HYPOPHAGIA 22 0.0009
520 MULTIPLE MYELOMA 4 0.0009
521 POLYURIA 7 0.0009
522 ALANINE AMINOTRANSFERASE INCREASED 52 0.0008
523 SINUS TACHYCARDIA 12 0.0008
524 FULL BLOOD COUNT DECREASED 17 0.0008
525 DEAFNESS 22 0.0008
526 HAEMODIALYSIS 7 0.0008
527 DEHYDRATION 111 0.0008
528 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
529 HEPATIC FAILURE 25 0.0008
530 BLOOD PHOSPHORUS DECREASED 3 0.0008
531 HEPATOTOXICITY 18 0.0008
532 STATUS EPILEPTICUS 9 0.0008
533 INTESTINAL OBSTRUCTION 30 0.0008
534 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
535 NEOPLASM 9 0.0008
536 NEUTROPHIL COUNT INCREASED 8 0.0008
537 VOMITING 367 0.0008
538 THERAPY NON-RESPONDER 35 0.0008
539 HAEMOLYSIS 6 0.0008
540 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
541 PERITONITIS 16 0.0008
542 PNEUMONITIS 21 0.0008
543 SKIN NECROSIS 4 0.0008
544 CARDIOPULMONARY FAILURE 3 0.0008
545 BLOOD POTASSIUM DECREASED 23 0.0008
546 RESPIRATORY ARREST 21 0.0008
547 STAPHYLOCOCCAL INFECTION 25 0.0008
548 SUDDEN DEATH 8 0.0008
549 RENAL FAILURE ACUTE 32 0.0008
550 PHARYNGOLARYNGEAL PAIN 4 0.0008
551 BLOOD CREATININE INCREASED 49 0.0007
552 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
553 ORGAN FAILURE 3 0.0007
554 COLITIS ISCHAEMIC 5 0.0007
555 PULMONARY FIBROSIS 14 0.0007
556 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
557 ANAPHYLACTOID REACTION 3 0.0007
558 BLOOD COUNT ABNORMAL 11 0.0007
559 DECREASED APPETITE 168 0.0007
560 CHOKING 14 0.0007
561 MALNUTRITION 8 0.0007
562 RENAL TUBULAR NECROSIS 7 0.0007
563 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
564 BUNDLE BRANCH BLOCK LEFT 3 0.0007
565 NEUROLOGICAL SYMPTOM 4 0.0007
566 GRAFT VERSUS HOST DISEASE 5 0.0007
567 PSYCHOLOGICAL TRAUMA 6 0.0007
568 HEPATIC LESION 3 0.0007
569 ABDOMINAL PAIN 161 0.0007
570 INFECTION 100 0.0007
571 DERMATITIS BULLOUS 5 0.0007
572 SPINAL OSTEOARTHRITIS 6 0.0007
573 PARONYCHIA 3 0.0007
574 ABDOMINAL ABSCESS 3 0.0007
575 STOMATITIS 41 0.0007
576 ACUTE RESPIRATORY FAILURE 13 0.0007
577 PULMONARY HYPERTENSION 14 0.0007
578 CHOLECYSTITIS 8 0.0007
579 HAEMORRHOIDS 13 0.0007
580 HEPATITIS CHOLESTATIC 4 0.0007
581 EATING DISORDER 14 0.0007
582 DISEASE COMPLICATION 3 0.0007
583 DEATH 562 0.0007
584 CIRCULATORY COLLAPSE 11 0.0006
585 AGRANULOCYTOSIS 12 0.0006
586 CYST 8 0.0006
587 HEPATIC FUNCTION ABNORMAL 24 0.0006
588 LEUKAEMIA 6 0.0006
589 PHOTOPSIA 4 0.0006
590 NEUROTOXICITY 11 0.0006
591 ATRIAL FLUTTER 5 0.0006
592 HYPOTHYROIDISM 20 0.0006
593 HYPOTENSION 124 0.0006
594 BLOOD POTASSIUM INCREASED 10 0.0006
595 ENCEPHALOPATHY 15 0.0006
596 PERICARDIAL EFFUSION 14 0.0006
597 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
598 ABDOMINAL TENDERNESS 3 0.0006
599 BRONCHIECTASIS 4 0.0006
600 HAEMATEMESIS 15 0.0006
601 LETHARGY 34 0.0006
602 PRODUCT USE ISSUE 111 0.0006
603 TRANSAMINASES INCREASED 13 0.0006
604 ECCHYMOSIS 4 0.0006
605 DEPRESSED LEVEL OF CONSCIOUSNESS 23 0.0006
606 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
607 PURPURA 5 0.0006
608 ANORECTAL DISCOMFORT 3 0.0006
609 RESPIRATORY RATE INCREASED 5 0.0006
610 ANAL FISTULA 3 0.0006
611 LUNG NEOPLASM MALIGNANT 23 0.0006
612 CONSTIPATION 122 0.0006
613 RECTAL HAEMORRHAGE 24 0.0006
614 NAUSEA 442 0.0006
615 BRUXISM 3 0.0006
616 NEUROPATHY PERIPHERAL 52 0.0005
617 INTESTINAL ISCHAEMIA 3 0.0005
618 OFF LABEL USE 476 0.0005
619 HYPOPHOSPHATAEMIA 4 0.0005
620 LIVER DISORDER 24 0.0005
621 BACTERIAL INFECTION 10 0.0005
622 APPENDICITIS 5 0.0005
623 ACUTE PULMONARY OEDEMA 3 0.0005
624 PULMONARY CONGESTION 7 0.0005
625 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
626 ACIDOSIS 4 0.0005
627 HERPES VIRUS INFECTION 3 0.0005
628 CHOLESTASIS 10 0.0005
629 ABDOMINAL DISTENSION 54 0.0005
630 LUNG INFECTION 8 0.0005
631 PALLOR 14 0.0005
632 HYPOVOLAEMIA 3 0.0005
633 LYMPHADENOPATHY 18 0.0005
634 VAGINAL HAEMORRHAGE 22 0.0005
635 CARDIAC FAILURE 40 0.0005
636 DRUG EFFECT INCOMPLETE 18 0.0005
637 TREATMENT FAILURE 41 0.0005
638 SUBARACHNOID HAEMORRHAGE 5 0.0005
639 RESPIRATORY DEPRESSION 6 0.0005
640 PARALYSIS 7 0.0005
641 HICCUPS 4 0.0005
642 CHILLS 57 0.0005
643 OLIGURIA 3 0.0005
644 DISORIENTATION 19 0.0005
645 BRAIN OEDEMA 6 0.0005
646 CONVULSION 27 0.0005
647 ENTERITIS 3 0.0005
648 RENAL FAILURE 62 0.0005
649 GENITAL HAEMORRHAGE 6 0.0005
650 ASPERGILLUS INFECTION 3 0.0005
651 PULMONARY EMBOLISM 43 0.0005
652 NEURALGIA 11 0.0005
653 CARDIAC FAILURE ACUTE 3 0.0004
654 MENINGITIS 3 0.0004
655 POSTOPERATIVE WOUND INFECTION 3 0.0004
656 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
657 PELVIC PAIN 8 0.0004
658 ONYCHOCLASIS 3 0.0004
659 ABDOMINAL PAIN LOWER 11 0.0004
660 CONFUSIONAL STATE 70 0.0004
661 APHASIA 13 0.0004
662 CARDIO-RESPIRATORY ARREST 18 0.0004
663 MASS 6 0.0004
664 ERYTHEMA MULTIFORME 4 0.0004
665 HYPERKALAEMIA 15 0.0004
666 MOUTH ULCERATION 9 0.0004
667 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
668 DIPLOPIA 11 0.0004
669 BLOOD PRESSURE DECREASED 28 0.0004
670 CYTOMEGALOVIRUS INFECTION 7 0.0004
671 URINARY RETENTION 14 0.0004
672 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
673 POLYNEUROPATHY 5 0.0004
674 DEEP VEIN THROMBOSIS 27 0.0004
675 PNEUMONIA 134 0.0004
676 HEMIPARESIS 7 0.0004
677 THERAPEUTIC RESPONSE DECREASED 25 0.0004
678 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
679 ASTHENIA 155 0.0004
680 HYPERGLYCAEMIA 15 0.0004
681 HYPERTENSION 87 0.0004
682 DIARRHOEA 265 0.0004
683 DYSURIA 15 0.0004
684 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
685 OEDEMA 22 0.0004
686 HYPERCALCAEMIA 5 0.0004
687 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
688 CARDIAC ARREST 33 0.0004
689 CYTOKINE RELEASE SYNDROME 8 0.0004
690 DYSPNOEA EXERTIONAL 15 0.0004
691 CELLULITIS 20 0.0004
692 VAGINAL DISCHARGE 4 0.0004
693 TOXICITY TO VARIOUS AGENTS 66 0.0004
694 PROCEDURAL COMPLICATION 3 0.0004
695 FUNGAL INFECTION 13 0.0004
696 NEOPLASM MALIGNANT 26 0.0004
697 FATIGUE 303 0.0004
698 APNOEA 3 0.0004
699 DERMATITIS 8 0.0004
700 PULMONARY OEDEMA 17 0.0004
701 SARS-COV-2 TEST POSITIVE 5 0.0004
702 INCONTINENCE 4 0.0004
703 CONJUNCTIVITIS 7 0.0004
704 ABSCESS 6 0.0004
705 HEPATIC STEATOSIS 7 0.0004
706 BLOOD DISORDER 3 0.0004
707 ASPIRATION 4 0.0004
708 HAIR DISORDER 3 0.0004
709 URINARY TRACT INFECTION 62 0.0004
710 GLAUCOMA 7 0.0004
711 ANAPHYLACTIC REACTION 20 0.0004
712 RASH MACULO-PAPULAR 8 0.0004
713 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
714 HAEMOPTYSIS 10 0.0004
715 ORAL PAIN 8 0.0004
716 NERVOUS SYSTEM DISORDER 11 0.0004
717 ALOPECIA 69 0.0004
718 ANURIA 3 0.0003
719 SKIN ULCER 9 0.0003
720 SHOCK 8 0.0003
721 ORTHOSTATIC HYPOTENSION 6 0.0003
722 LOCAL SWELLING 6 0.0003
723 IMMUNOSUPPRESSION 3 0.0003
724 OEDEMA PERIPHERAL 41 0.0003
725 FACIAL PAIN 3 0.0003
726 THIRST 6 0.0003
727 PULMONARY MASS 5 0.0003
728 HAEMOLYTIC ANAEMIA 3 0.0003
729 VISUAL ACUITY REDUCED 11 0.0003
730 DYSPNOEA 187 0.0003
731 OPTIC NEURITIS 3 0.0003
732 BRAIN NEOPLASM 3 0.0003
733 GENERALISED OEDEMA 4 0.0003
734 MUSCULOSKELETAL CHEST PAIN 5 0.0003
735 PHARYNGITIS 4 0.0003
736 NEPHROPATHY 3 0.0003
737 OXYGEN SATURATION DECREASED 18 0.0003
738 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
739 SLEEP APNOEA SYNDROME 6 0.0003
740 HEPATIC CYTOLYSIS 4 0.0003
741 PANCREATITIS ACUTE 7 0.0003
742 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
743 DIZZINESS POSTURAL 3 0.0003
744 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
745 NODULE 4 0.0003
746 BEDRIDDEN 4 0.0003
747 GASTRITIS 8 0.0003
748 ORAL CANDIDIASIS 4 0.0003
749 WHEEZING 18 0.0003
750 IMMUNE SYSTEM DISORDER 4 0.0003
751 VENTRICULAR TACHYCARDIA 5 0.0003
752 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
753 MOTOR DYSFUNCTION 3 0.0003
754 PERIPHERAL COLDNESS 4 0.0003
755 BONE PAIN 17 0.0003
756 DELIRIUM 10 0.0003
757 INFUSION RELATED REACTION 19 0.0003
758 COUGH 80 0.0003
759 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
760 FULL BLOOD COUNT ABNORMAL 3 0.0003
761 PNEUMONIA ASPIRATION 7 0.0003
762 RENAL DISORDER 13 0.0003
763 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
764 OSTEOMYELITIS 5 0.0003
765 FLUID OVERLOAD 4 0.0003
766 CHOLELITHIASIS 9 0.0003
767 GASTROENTERITIS 4 0.0003
768 RENAL IMPAIRMENT 23 0.0003
769 MELAENA 6 0.0003
770 VIRAL INFECTION 9 0.0003
771 HAEMATOMA 7 0.0003
772 HYPERTENSIVE CRISIS 3 0.0003
773 CATARACT 16 0.0003
774 WEIGHT DECREASED 75 0.0003
775 HAEMORRHAGE 28 0.0003
776 SEDATION 7 0.0003
777 LUNG DISORDER 13 0.0003
778 MYOCARDIAL ISCHAEMIA 3 0.0003
779 ILL-DEFINED DISORDER 16 0.0003
780 EAR INFECTION 7 0.0003
781 MYOCARDITIS 3 0.0003
782 DRUG ADMINISTRATION ERROR 8 0.0003
783 JAUNDICE 7 0.0003
784 SYNCOPE 26 0.0003
785 EAR PAIN 5 0.0003
786 KIDNEY INFECTION 5 0.0003
787 CYANOSIS 4 0.0003
788 SINUS DISORDER 5 0.0003
789 COMA 12 0.0003
790 PRODUCTIVE COUGH 12 0.0003
791 METABOLIC ACIDOSIS 8 0.0002
792 SENSORY DISTURBANCE 4 0.0002
793 HEART RATE INCREASED 24 0.0002
794 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
795 HAIR COLOUR CHANGES 3 0.0002
796 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
797 RHINORRHOEA 15 0.0002
798 DYSPHAGIA 22 0.0002
799 HIATUS HERNIA 3 0.0002
800 DRUG INEFFECTIVE 302 0.0002
801 MUSCULOSKELETAL PAIN 12 0.0002
802 EPILEPSY 7 0.0002
803 ACUTE KIDNEY INJURY 35 0.0002
804 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
805 EYE HAEMORRHAGE 3 0.0002
806 HAIR TEXTURE ABNORMAL 3 0.0002
807 ISCHAEMIC STROKE 4 0.0002
808 JOINT RANGE OF MOTION DECREASED 3 0.0002
809 CHEST PAIN 41 0.0002
810 LEUKOCYTOSIS 4 0.0002
811 IMPAIRED GASTRIC EMPTYING 3 0.0002
812 GINGIVAL BLEEDING 3 0.0002
813 BACK PAIN 50 0.0002
814 NECK PAIN 12 0.0002
815 COGNITIVE DISORDER 10 0.0002
816 ADVERSE DRUG REACTION 19 0.0002
817 PAIN 128 0.0002
818 DIABETIC KETOACIDOSIS 5 0.0002
819 HYPERTHYROIDISM 3 0.0002
820 HERNIA 4 0.0002
821 HYPERSENSITIVITY 38 0.0002
822 DYSGEUSIA 15 0.0002
823 VISUAL IMPAIRMENT 25 0.0002
824 IMMUNODEFICIENCY 3 0.0002
825 PAIN IN EXTREMITY 59 0.0002
826 FEEDING DISORDER 4 0.0002
827 DEVICE FAILURE 3 0.0002
828 CARDIOVASCULAR DISORDER 5 0.0002
829 BLINDNESS 8 0.0002
830 CEREBRAL HAEMORRHAGE 7 0.0002
831 HEPATITIS 5 0.0002
832 ATRIAL FIBRILLATION 19 0.0002
833 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
834 ANAPHYLACTIC SHOCK 5 0.0002
835 UNRESPONSIVE TO STIMULI 5 0.0002
836 RESPIRATORY TRACT INFECTION 5 0.0002
837 HERPES ZOSTER 11 0.0002
838 CONDITION AGGRAVATED 58 0.0002
839 PANCREATITIS 10 0.0002
840 COLORECTAL CANCER 9 0.0002
841 CYSTITIS 6 0.0002
842 DYSARTHRIA 7 0.0002
843 OSTEONECROSIS 6 0.0002
844 SKIN LESION 5 0.0002
845 SEIZURE 21 0.0002
846 SWELLING 17 0.0002
847 FLATULENCE 10 0.0002
848 DRUG INTOLERANCE 17 0.0002
849 INFLAMMATION 9 0.0002
850 MUSCULOSKELETAL DISCOMFORT 3 0.0002
851 THROMBOSIS 14 0.0002
852 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
853 CARDIAC DISORDER 16 0.0002
854 GASTROINTESTINAL DISORDER 15 0.0002
855 GOUT 3 0.0002
856 LACRIMATION INCREASED 5 0.0002
857 VERTIGO 10 0.0002
858 SOMNOLENCE 33 0.0002
859 CEREBRAL INFARCTION 4 0.0002
860 HYPOACUSIS 7 0.0002
861 MEDICATION ERROR 9 0.0002
862 BLOOD URINE PRESENT 3 0.0002
863 GASTRIC ULCER 3 0.0002
864 THERAPY CESSATION 8 0.0002
865 BRADYCARDIA 8 0.0002
866 CARDIAC FAILURE CONGESTIVE 12 0.0001
867 MALAISE 65 0.0001
868 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
869 HEPATIC ENZYME INCREASED 10 0.0001
870 ABDOMINAL PAIN UPPER 30 0.0001
871 DIZZINESS 72 0.0001
872 WOUND 4 0.0001
873 HALLUCINATION, VISUAL 3 0.0001
874 PAIN IN JAW 4 0.0001
875 RASH 61 0.0001
876 ANGINA PECTORIS 4 0.0001
877 HYPERSOMNIA 4 0.0001
878 DEVICE LEAKAGE 6 0.0001
879 FLUSHING 14 0.0001
880 PRODUCT PRESCRIBING ISSUE 3 0.0001
881 LIVER FUNCTION TEST ABNORMAL 4 0.0001
882 HOSPITALISATION 21 0.0001
883 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
884 ERYTHEMA 28 0.0001
885 LABORATORY TEST ABNORMAL 4 0.0001
886 BRONCHITIS 10 0.0001
887 RESPIRATORY DISORDER 4 0.0001
888 PARAESTHESIA 21 0.0001
889 DYSPEPSIA 13 0.0001
890 ADVERSE EVENT 12 0.0001
891 HEADACHE 81 0.0001
892 MOVEMENT DISORDER 4 0.0001
893 NIGHT SWEATS 4 0.0001
894 LACTIC ACIDOSIS 4 0.0001
895 MUSCULAR WEAKNESS 14 0.0001
896 IMPAIRED HEALING 4 0.0001
897 OSTEONECROSIS OF JAW 3 0.0001
898 DRY EYE 6 0.0001
899 SKIN DISORDER 4 0.0001
900 GAIT INABILITY 4 0.0001
901 DYSPHONIA 7 0.0001
902 DISCOMFORT 7 0.0001
903 SPEECH DISORDER 6 0.0001
904 RASH MACULAR 4 0.0001
905 TREATMENT NONCOMPLIANCE 6 0.0001
906 ACCIDENTAL OVERDOSE 4 0.0001
907 LOSS OF CONSCIOUSNESS 14 0.0001
908 VISION BLURRED 15 0.0001
909 BLISTER 6 0.0001
910 FALL 35 0.0001
911 GAIT DISTURBANCE 20 0.0001
912 BLOOD GLUCOSE DECREASED 5 0.0001
913 PSYCHOTIC DISORDER 3 0.0001
914 ABDOMINAL DISCOMFORT 17 0.0001
915 ABNORMAL BEHAVIOUR 4 0.0001
916 DRUG INTERACTION 16 0.0001
917 DRY MOUTH 8 0.0001
918 THERAPY INTERRUPTED 7 0.0001
919 FEELING HOT 6 0.0001
920 CHEST DISCOMFORT 10 0.0001
921 OROPHARYNGEAL PAIN 9 0.0001
922 POLLAKIURIA 4 0.0001
923 DRUG-INDUCED LIVER INJURY 3 0.0001
924 ECZEMA 5 0.0001
925 AGITATION 7 0.0001
926 HEAD INJURY 3 0.0001
927 INSOMNIA 25 0.0001
928 DRUG EFFECT DECREASED 5 0.0001
929 UNEVALUABLE EVENT 7 0.0001
930 SWELLING FACE 6 0.0001
931 DEVICE DISLOCATION 4 0.0001
932 MYOCARDIAL INFARCTION 16 0.0001
933 EYE DISORDER 3 0.0001
934 HAEMATOCHEZIA 5 0.0001
935 TREMOR 15 0.0001
936 CEREBROVASCULAR ACCIDENT 15 0.0001
937 PRURITUS 34 0.0001
938 TINNITUS 4 0.0001
939 HYPOAESTHESIA 13 0.0001
940 BURNING SENSATION 6 0.0001
941 HEART RATE DECREASED 3 0.0001
942 PALPITATIONS 10 0.0001
943 NASAL CONGESTION 5 0.0001
944 OCULAR HYPERAEMIA 4 0.0001
945 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
946 CONTUSION 8 0.0001
947 HYPOGLYCAEMIA 4 0.0001
948 AMNESIA 5 0.0001
949 DRY SKIN 10 0.0001
950 DEPRESSION 17 0.0001
951 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
952 INJECTION SITE REACTION 5 0.0001
953 BLOOD PRESSURE INCREASED 11 0.0001
954 PERIPHERAL SWELLING 11 0.0001
955 SLEEP DISORDER 5 0.0001
956 ANXIETY 20 0.0001
957 HYPERHIDROSIS 9 0.0001
958 ARTHRALGIA 29 0.0001
959 MENTAL DISORDER 3 0.0001
960 PRODUCT STORAGE ERROR 6 0.0001
961 ANGIOEDEMA 3 0.0001
962 URTICARIA 11 0.0001
963 BLOOD CHOLESTEROL INCREASED 3 0.0001
964 BLOOD GLUCOSE INCREASED 12 0.0001
965 ARRHYTHMIA 3 0.0001
966 MUSCLE SPASMS 11 0.0001
967 AGGRESSION 3 0.0001
968 SKIN EXFOLIATION 5 0.0001
969 FLUID RETENTION 3 0.0001
970 MYALGIA 10 0.0001
971 DISTURBANCE IN ATTENTION 3 0.0001
972 HOT FLUSH 4 0.0001
973 DIABETES MELLITUS 4 0.0001
974 EYE IRRITATION 3 0.0001
975 IRRITABILITY 3 0.0000
976 JOINT SWELLING 6 0.0000
977 SINUSITIS 5 0.0000
978 ILLNESS 5 0.0000
979 BALANCE DISORDER 4 0.0000
980 FEELING ABNORMAL 11 0.0000
981 INFLUENZA 5 0.0000
982 MEMORY IMPAIRMENT 6 0.0000
983 DRUG DOSE OMISSION 7 0.0000
984 CHRONIC KIDNEY DISEASE 3 0.0000
985 ARTHRITIS 3 0.0000
986 INFLUENZA LIKE ILLNESS 3 0.0000
987 WEIGHT INCREASED 8 0.0000
988 OVERDOSE 7 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
990 NASOPHARYNGITIS 5 0.0000
991 ASTHMA 3 0.0000
992 EMOTIONAL DISTRESS 3 0.0000
993 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
994 NO ADVERSE EVENT 4 0.0000
995 INCORRECT DOSE ADMINISTERED 5 0.0000
996 INJECTION SITE PAIN 4 0.0000